Astellas Pharma (Netherlands)

437 papers and 11.2k indexed citations i.

About

In recent decades, authors affiliated with Astellas Pharma (Netherlands) have published 437 papers, which have received a total of 11.2k indexed citations. Scholars at this organization have produced 122 papers in Urology, 99 papers in Epidemiology and 95 papers in Pulmonary and Respiratory Medicine on the topics of Urinary Bladder and Prostate Research (121 papers), Pelvic Floor Disorders (87 papers) and Prostate Cancer Treatment and Research (76 papers). Their work is cited by papers focused on Urology (3.3k citations), Rheumatology (2.5k citations) and Epidemiology (2.5k citations). Authors at Astellas Pharma (Netherlands) collaborate with scholars in The Netherlands, United States and United Kingdom and have published in prestigious journals including Journal of Clinical Oncology, Blood and PLoS ONE. Some of Astellas Pharma (Netherlands)'s most productive authors include Christopher R. Chapple, Michael Reusch, Zalmaï Hakimi, Emad Siddiqui, Tadao Akizawa, Jameel Nazir, Malcolm Stoker, Caroline A. Dorrepaal, Meindert Danhof and Ted Drogendijk.

In The Last Decade

Fields of papers published by authors at Astellas Pharma (Netherlands)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Astellas Pharma (Netherlands) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Astellas Pharma (Netherlands) at the time of their publication.

Countries citing scholars working at Astellas Pharma (Netherlands)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Astellas Pharma (Netherlands). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Astellas Pharma (Netherlands) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astellas Pharma (Netherlands) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025